Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)
Clinical trial NCT00725075 · COMPLETED
Trial details
- NCT number
- NCT00725075
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-10
- Primary completion
- 2008-10-24
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.